Error: Could not add to watchlist. X

Talon Therapeutics Inc

+ Watchlist
TLON:US
Acquired
TLON:US was acquired by SPPI:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.970
Market Cap (USD)
-
Shares Outstanding (m)
22.012
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Talon Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing cancer therapies. The Company's lead product candidate potentially treats acute lymphoblastic leukemia and lymphomas.
ADDRESS
400 Oyster Point Blvd.
Suite 200
San Francisco, CA 94080
United States
PHONE
1-650-588-6404
  • Steven R Deitcher
    President/CEO
  • Craig W Carlson
    Senior VP/CFO
  • Thomas J Tarlow
    VP:Regulatory Affairs
  • Thomas Dezao
    VP:Commercial Ops & Planning
  • Samir M Gharib
    Director:Finance/Controller
Show More